OriGene Buys Marligen Biosciences | GenomeWeb

NEW YORK (GenomeWeb News) – OriGene Technologies has acquired Marligen Biosciences, a privately held seller of DNA and RNA purification kits and multiplex assays for genotyping, microRNA profiling, and transcription factor activity analysis.

Rockville, Md.-based OriGene makes gene cloning and gene expression tools. OriGene raised $6.5 million earlier this year in a private equity financing to support its acquisition of Shenzhen P&A Biotech, a manufacturer of monoclonal antibodies.

The firms did not disclose the purchase price.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.